Suppression of NFκB activation and NFκB‐dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5‐lipoxygenase
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Tepoxalin, a dual inhibitor of cyclooxygenase (CO) and 5‐lipoxygenase (5LO) with cytokine modifying activity, is also a potent inhibitor of the transcription factor, nuclear factor κB (NFκB). NFκB is a pleiotropic activator that is involved in the regulation of many genes whose products participate in immune or inflammatory responses. Tepoxalin inhibited in a dose related manner NFκB activation by PMA + ionomycin or H 2 O 2 in Jurkat and HeLa cells. TNF‐α‐induced NFκB was also inhibited by tepoxalin in HeLa cells, while relatively less marked inhibition was observed in Jurkat cells. Activation of NFκB in several monocytic cell lines was also suppressed by tepoxalin. However AP‐1 stimulation under the same conditions was not affected by tepoxalin. Other CO, LO inhibitors such as naproxen or zileuton did not inhibit NFκB activities. This inhibitory activity of tepoxalin was further illustrated by its suppression of NFκB regulated genes such as IL‐6 in PMA stimulated human PBL and c‐myc in IL‐2 dependent T cell lines. Tepoxalin also blocked PMA + ionomycin‐induced IκB degradation in a time‐dependent fashion. The possible mechanism of tepoxalin in NFκB activation and its potential clinical application are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
Schreck, R., Meier, B., Männel, D. N., Dröge, W., & Baeuerle, P. A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1181 · Cited by 1,508
Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro.
Toledano, M. B., & Leonard, W. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4328 · Cited by 657
Cited by
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Tissue-specific functions of individual glutathione peroxidases
Brigelius-Flohé, R. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00173-2 · Cited by 1,114
Redox Regulation of NF-kappa B Activation
Flohé, L., Brigelius-Flohé, R., Saliou, C., Traber, M. G., & Packer, L. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00501-1 · Cited by 859
Baeuerle, P. A., & Baichwal, V. R. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60742-7 · Cited by 511
Role of transcription factors in inflammatory lung diseases
Rahman, I., & MacNee, W. (1998) · Thorax · doi:10.1136/thx.53.7.601 · Cited by 468
Metadata
- Authors
- Kazmi, S. M. I., Plante, R. K., Visconti, V., Taylor, G. R., Zhou, L., & Lau, C. Y.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 1995-02
- Volume
- 57
- Issue
- 2
- Pages
- 299-310
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W1968019392
- Cited by
- 76
- References
- 2
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Suppression of NFκB activation and NFκB‐dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5‐lipoxygenase. https://app.cochat.ai/papers/10.1002/jcb.240570214
- The paper
- Kazmi, S. M. I., Plante, R. K., Visconti, V., Taylor, G. R., Zhou, L., & Lau, C. Y. (1995). Suppression of NFκB activation and NFκB‐dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5‐lipoxygenase. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.240570214
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.